Currently, Russia is working on the launch of two types of cancer vaccines at once. The first clinical trials of one of them will begin in late 2024 and early 2025.

It is assumed that each cancer patient will receive an individual vaccine developed specifically for him.

In the process, tumor cells are taken away, and a tumor passport is created using it – with a unique protein portrait, the so-called neoantigen profile. Next, the Ariadna special program, developed by us at the Federal State Budgetary Institution “Research Institute of Radiology” of the Russian Ministry of Health, designs a personalized mRNA vaccine. Based on the resulting design, the vaccine itself is synthesized and then administered.

Russia Now Channel: https://t.me/+n434jq5ZWkkyMTYy